Edition:
India

GBT Announces Results of Post-hoc Analysis of Phase 3 HOPE Study Showing Improvement in Leg Ulcers in Patients with Sickle Cell Disease Treated with Voxelotor


Monday, 21 Oct 2019 

Oct 21 (Reuters) - Global Blood Therapeutics Inc ::ANNOUNCES RESULTS OF POST-HOC ANALYSIS OF PHASE 3 HOPE STUDY SHOWING IMPROVEMENT IN LEG ULCERS IN PATIENTS WITH SICKLE CELL DISEASE TREATED WITH VOXELOTOR.GLOBAL BLOOD THERAPEUTICS - ‍RESULTS OF EXPLORATORY ANALYSIS SUGGEST VOXELOTOR RESOLVED OR REDUCED SEVERITY OF EXISTING LEG ULCERS​.GLOBAL BLOOD THERAPEUTICS - ‍RESULTS OF EXPLORATORY ANALYSIS SUGGEST VOXELOTOR DECREASED INCIDENCE OF NEW LEG ULCERS IN PATIENTS WITH SCD​.